To evaluate and compare the safety and efficacy of skin care formulation in terms of moisturization and Skin Barrier Function (trans epidermal water loss) versus untreated control on healthy human subjects - NI

SATIYA NUTRACEUTICALS PRIVATE LIMITED0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•1)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
•2)Subject having dry skin with corneometer reading less than 30 on forearms

•1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.Having refused to give her assent by signing the consent form.
•2)Taking part in another study liable to interfere with this study.
•3)Being known diabetic case
•4)Known asthma case
•5)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
•6)Being known thyroid case
•7)Being epileptic.
•8)Following a chronic medicinal treatment comprising any of the following product: aspirin-based product, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
•9)Known case of hypersensitivity.
•10)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic product.
•11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
•12)Having changed their cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
•13)Having applied a cosmetic product (included make-up) on the studied areas 48 hours prior study.

发起方

SATIYA NUTRACEUTICALS PRIVATE LIMITED